The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia.

Ther Adv Hematol · 2025 · PMC12202931 · PMID 40585520

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

For all patients, the VAF of most genes showed a decreasing trend from diagnosis to C1D1 period ( Figures 4(a) and S2 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.